S2302: PRAGMATICA - LUNG: A Prospective Randomized Study of Ramucirumab (LY3009806; NSC 749128) plus Pembrolizumab (MK-3475; NSC 776864) versus Standard of Care for Participants Previously Treated with Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

Rocky Mountain Regional VA Medical Center

Principal Investigator
Photograph of Jessica McDermott

Jessica McDermott

Study ID

Protocol Number: 23-0174

More information available at ClinicalTrials.gov: NCT05633602

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers